Vertex Pharmaceuticals Incorporated vs Keyence Corporation
Market cap comparison over time
Vertex Pharmaceuticals Incorporated
$134.2B
Rank #126
Keyence Corporation
$138.1B
Rank #123
Market Cap Over Time
Key Moments
- Keyence Corporation overtook Vertex Pharmaceuticals Incorporated by 2002
- Vertex Pharmaceuticals Incorporated overtook Keyence Corporation by 2006
- Keyence Corporation overtook Vertex Pharmaceuticals Incorporated by 2007
- Vertex Pharmaceuticals Incorporated overtook Keyence Corporation by 2008
- Keyence Corporation overtook Vertex Pharmaceuticals Incorporated by 2016
- Vertex Pharmaceuticals Incorporated overtook Keyence Corporation by 2023
- Keyence Corporation overtook Vertex Pharmaceuticals Incorporated by 2024
- Vertex Pharmaceuticals Incorporated overtook Keyence Corporation by 2025
- Keyence Corporation overtook Vertex Pharmaceuticals Incorporated by 2026
Year-by-Year Comparison
| Year | Vertex Pharmaceuticals Incorporated | Keyence Corporation | Leader |
|---|---|---|---|
| 2026 | $134.2B | $138.1B | Keyence Corporation |
| 2025 | $115.1B | $91.7B | Vertex Pharmaceuticals Incorporated |
| 2024 | $102.2B | $103.7B | Keyence Corporation |
| 2023 | $103.3B | $99.2B | Vertex Pharmaceuticals Incorporated |
| 2022 | $73.3B | $81.7B | Keyence Corporation |
| 2021 | $55.7B | $114.3B | Keyence Corporation |
| 2020 | $60.0B | $91.4B | Keyence Corporation |
| 2019 | $55.6B | $60.3B | Keyence Corporation |
| 2018 | $42.1B | $43.5B | Keyence Corporation |
| 2017 | $38.0B | $49.2B | Keyence Corporation |
| 2016 | $18.7B | $31.2B | Keyence Corporation |
| 2015 | $31.9B | $26.0B | Vertex Pharmaceuticals Incorporated |
| 2014 | $30.2B | $20.8B | Vertex Pharmaceuticals Incorporated |
| 2013 | $18.9B | $17.4B | Vertex Pharmaceuticals Incorporated |
| 2012 | $10.6B | $9.2B | Vertex Pharmaceuticals Incorporated |
| 2011 | $8.4B | $6.5B | Vertex Pharmaceuticals Incorporated |
| 2010 | $8.9B | $8.2B | Vertex Pharmaceuticals Incorporated |
| 2009 | $10.9B | $6.7B | Vertex Pharmaceuticals Incorporated |
| 2008 | $7.7B | $5.2B | Vertex Pharmaceuticals Incorporated |
| 2007 | $5.9B | $7.9B | Keyence Corporation |
| 2006 | $9.5B | $9.2B | Vertex Pharmaceuticals Incorporated |
| 2005 | $7.0B | $9.5B | Keyence Corporation |
| 2004 | $2.7B | $5.4B | Keyence Corporation |
| 2003 | $2.6B | $5.3B | Keyence Corporation |
| 2002 | $4.0B | $4.8B | Keyence Corporation |
| 2001 | $6.2B | $5.1B | Vertex Pharmaceuticals Incorporated |